Evidence map›Paper›PMID 23178850›Full record

ReviewCellular and molecular life sciences : CMLS2013

AID and Apobec3G haphazard deamination and mutational diversity.

Malgorzata Jaszczur, Jeffrey G Bertram, Phuong Pham, Matthew D Scharff, Myron F Goodman

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Random-walk enzymes.Physical review. E, Statistical, nonlinear, and soft matter physics · 2015
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Malgorzata JaszczurDepartments of Biological Sciences and Chemistry, Molecular and Computational Biology Section, University of Southern California, Los Angeles, CA 90089-2910, USA.
Jeffrey G Bertram
Phuong Pham
Matthew D Scharff
Myron F Goodman

Funding

SOMATIC MUTATION OF IG VARIABLE REGIONSR01CA072649 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1997 to 2014
$5.0M
Biochemical Basis of Somatic HypermutationR01ES013192 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GOODMAN, MYRON · 2004 to 2013
$3.7M
ERROR CORRECTION IN DNA SYNTHESIS--A BIOCHEMICAL STUDYR37GM021422 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GOODMAN, MYRON · 2000 to 2009
$3.5M
Mismatch repair in V region mutation and isotype switchingR01CA102705 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 2003 to 2013
$3.2M
ERROR CORRECTION IN DNA SYNTHESIS: A BIOCHEMICAL STUDYR01GM021422 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GOODMAN, MYRON · 1985 to 2014
$1.6M
Biochemical Basis of Somatic HypermutationR56ES013192 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GOODMAN, MYRON · 2015 to 2015
$150k
NCI NIH HHS CA102705NCI NIH HHS CA72649NCI NIH HHS R01 CA072649NCI NIH HHS R01 CA102705NIEHS NIH HHS ES13192NIEHS NIH HHS R01 ES013192NIEHS NIH HHS R56 ES013192NIGMS NIH HHS GM21422NIGMS NIH HHS R01 GM021422NIGMS NIH HHS R37 GM021422
6 · The paper itself

Abstract

Activation-induced deoxycytidine deaminase (AID) and Apobec 3G (Apo3G) cause mutational diversity by initiating mutations on regions of single-stranded (ss) DNA. Expressed in B cells, AID deaminates C → U in actively transcribed immunoglobulin (Ig) variable and switch regions to initiate the somatic hypermutation (SHM) and class switch recombination (CSR) that are essential for antibody diversity. Apo3G expressed in T cells catalyzes C deaminations on reverse transcribed cDNA causing HIV-1 retroviral inactivation. When operating properly, AID- and Apo3G-initiated mutations boost human fitness. Yet, both enzymes are potentially powerful somatic cell "mutators". Loss of regulated expression and proper genome targeting can cause human cancer. Here, we review well-established biological roles of AID and Apo3G. We provide a synopsis of AID partnering proteins during SHM and CSR, and describe how an Apo2 crystal structure provides "surrogate" insight for AID and Apo3G biochemical behavior. However, large gaps remain in our understanding of how dC deaminases search ssDNA to identify trinucleotide motifs to deaminate. We discuss two recent methods to analyze ssDNA scanning and deamination. Apo3G scanning and deamination is visualized in real-time using single-molecule FRET, and AID deamination efficiencies are determined with a random walk analysis. AID and Apo3G encounter many candidate deamination sites while scanning ssDNA. Generating mutational diversity is a principal aim of AID and an important ancillary property of Apo3G. Success seems likely to involve hit and miss deamination motif targeting, biased strongly toward miss.

Indexed as

Genetic VariationMutationAICDA (Activation-Induced Cytidine Deaminase)Antibody DiversityAPOBEC-3G DeaminaseB-LymphocytesCytidine DeaminaseDeaminationDrug Delivery SystemsHumansSingle-Chain AntibodiesAICDA (Activation-Induced Cytidine Deaminase)APOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine DeaminaseSingle-Chain Antibodies

Identifiers

PMID23178850
PMCPMC3600397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.